摘要
British Journal of DermatologyVolume 186, Issue 2 p. 379-381 Research letter Real-world effectiveness of brentuximab vedotin in the treatment of CD30-positive cutaneous T-cell lymphoma: a single-centre retrospective review M.-H. Henderson Berg, Corresponding Author M.-H. Henderson Berg meagan-helen.hendersonberg@mail.mcgill.ca orcid.org/0000-0002-4622-2931 Division of Dermatology, McGill University, Montreal, QC, Canada Contribution: Conceptualization (equal), Data curation (lead), Formal analysis (lead), Investigation (lead), Methodology (equal), Writing - original draft (lead), Writing - review & editing (equal)Search for more papers by this authorK. Davison, K. Davison Division of Hematology, McGill University, Montreal, QC, Canada Contribution: Writing - review & editing (equal)Search for more papers by this authorG. Popradi, G. Popradi Division of Hematology, McGill University, Montreal, QC, Canada Contribution: Conceptualization (equal), Methodology (equal), Supervision (lead), Writing - review & editing (equal)Search for more papers by this author M.-H. Henderson Berg, Corresponding Author M.-H. Henderson Berg meagan-helen.hendersonberg@mail.mcgill.ca orcid.org/0000-0002-4622-2931 Division of Dermatology, McGill University, Montreal, QC, Canada Contribution: Conceptualization (equal), Data curation (lead), Formal analysis (lead), Investigation (lead), Methodology (equal), Writing - original draft (lead), Writing - review & editing (equal)Search for more papers by this authorK. Davison, K. Davison Division of Hematology, McGill University, Montreal, QC, Canada Contribution: Writing - review & editing (equal)Search for more papers by this authorG. Popradi, G. Popradi Division of Hematology, McGill University, Montreal, QC, Canada Contribution: Conceptualization (equal), Methodology (equal), Supervision (lead), Writing - review & editing (equal)Search for more papers by this author First published: 05 October 2021 https://doi.org/10.1111/bjd.20786 Funding sources: none. Conflicts of interest: the authors declare they have no conflicts of interest. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat No abstract is available for this article. Volume186, Issue2February 2022Pages 379-381 RelatedInformation